Assured Vaporizing Chest Rub

Description

Assured Vaporizing Chest Rub is a topical formulation designed for application to the chest area. It is intended to provide a soothing effect and is typically used to relieve symptoms associated with respiratory discomfort. The product is characterized by its semi-solid consistency, allowing for easy application. The formulation includes a blend of active ingredients that contribute to its therapeutic properties. The specific composition and concentration of these ingredients are proprietary. The product is packaged in a suitable container to maintain stability and efficacy during storage.

Uses and Indications

This drug is indicated for the temporary relief of cough when applied to the chest and throat. Additionally, it is indicated for the temporary relief of minor aches and pains when applied to aching muscles.

There are no teratogenic or nonteratogenic effects associated with this drug.

Dosage and Administration

Adults and children over 2 years of age are instructed to apply a thick layer of the product to the chest and throat to provide temporary relief from nasal congestion and coughing associated with colds. If desired, the application may be covered with a dry, warm cloth; however, it is important to keep clothing loose to allow the vapors to rise to the nose and mouth. This application may be repeated up to three times daily, particularly at bedtime, or as directed by a healthcare professional.

For children under 2 years of age, it is essential to consult a doctor prior to use.

The product is intended for topical application on the chest and throat, and the method of administration involves rubbing a thick layer onto the skin. The recommended frequency of application is up to three times daily, with an emphasis on use at bedtime.

Contraindications

Use is contraindicated in patients who experience a cough that persists for more than one week, tends to recur, or is accompanied by fever, rash, or persistent headache. In such cases, consultation with a healthcare professional is advised to determine the appropriate course of action.

Warnings and Precautions

For external use only; this product must not be ingested or placed in the nostrils. It is imperative to avoid exposure to excessive heat. The product should never be exposed to flame or placed in any container intended for heating water. Additionally, it must not be placed in a microwave oven.

In the event of accidental ingestion, it is crucial to seek professional assistance immediately or contact a Poison Control Centre for guidance.

Healthcare professionals should advise patients to consult a doctor and discontinue use if a cough persists for more than one week, recurs, or is accompanied by fever, rash, or a persistent headache.

Side Effects

Patients should be aware that this product is for external use only and should not be ingested or placed in the nostrils. It is important to avoid excessive heat and to never expose the product to flame or place it in any container used for heating water. Additionally, the product should not be placed in a microwave oven.

In clinical practice, patients are advised to consult a doctor and discontinue use if their cough persists for more than one week, tends to recur, or is accompanied by fever, rash, or a persistent headache. These symptoms may indicate a more serious underlying condition that requires medical attention.

Drug Interactions

No drug interactions or drug and laboratory test interactions have been identified for this product. Therefore, no specific recommendations for dosage adjustments or monitoring are necessary at this time.

Packaging & NDC

Below are the non-prescription pack sizes of Assured Vaporizing Chest Rub (camphor and eucalyptus oil and menthol). Columns show Packaging, Formulation Type, and Active Ingredient Strength.

Pediatric Use

Pediatric patients over 2 years of age may use the product by applying a thick layer on the chest and throat to provide temporary relief from nasal congestion and coughing associated with colds. For children under 2 years of age, it is advised to consult a doctor prior to use.

Geriatric Use

There is no specific information regarding the use of this medication in geriatric patients, including dosage adjustments, safety concerns, or special precautions. Healthcare providers should exercise caution when prescribing this medication to elderly patients, as they may have altered pharmacokinetics and pharmacodynamics. Close monitoring is recommended to ensure safety and efficacy in this population.

Pregnancy

There is no specific information available regarding the use of this medication during pregnancy, including safety concerns, dosage modifications, or special precautions. Healthcare professionals should consider the lack of data when prescribing this medication to pregnant patients and weigh the potential risks and benefits. Women of childbearing potential should be counseled on the absence of established safety data and the importance of discussing any potential pregnancy with their healthcare provider.

Lactation

There are no specific warnings or recommendations regarding the use of this product by lactating mothers. Additionally, there is no information available about the potential for excretion in breast milk or any associated risks to breastfed infants.

Renal Impairment

Patients with renal impairment have not been specifically addressed in the available prescribing information. There are no dosage adjustments, special monitoring requirements, or safety considerations outlined for individuals with reduced kidney function. Healthcare professionals should exercise caution and consider the lack of data when prescribing to this patient population.

Hepatic Impairment

Patients with hepatic impairment have not been specifically studied in relation to the use of this medication. Consequently, there are no established dosage adjustments, special monitoring requirements, or precautions outlined for individuals with compromised liver function. It is recommended that healthcare providers exercise caution when prescribing this medication to patients with hepatic impairment, given the lack of data on its safety and efficacy in this population. Regular monitoring of liver function may be prudent in these cases, although specific parameters are not defined in the available information.

Overdosage

In the absence of specific information regarding overdosage, healthcare professionals are advised to exercise caution and adhere to general principles of management in cases of suspected overdose.

It is essential to monitor the patient closely for any potential symptoms that may arise from an overdose. Symptoms can vary widely depending on the substance involved and the individual patient's response.

In the event of an overdose, immediate medical attention should be sought. Healthcare providers should initiate supportive care, which may include maintaining airway patency, providing supplemental oxygen, and monitoring vital signs.

If the substance involved is known, specific antidotes or treatments may be indicated, and healthcare professionals should refer to established guidelines for the management of overdose related to that substance.

In all cases, contacting a poison control center or a medical toxicologist for guidance is recommended to ensure appropriate management and intervention.

Nonclinical Toxicology

No teratogenic or non-teratogenic effects have been reported in the available nonclinical studies. Additionally, there is no information regarding animal pharmacology and toxicology. The absence of data limits the understanding of potential risks associated with the compound in nonclinical settings.

Postmarketing Experience

No postmarketing experience details are available in the insert text.

Patient Counseling

Healthcare providers should advise patients to keep the medication out of reach of children to prevent accidental ingestion. In the event of accidental ingestion, patients should be instructed to seek professional assistance or contact a Poison Control Centre immediately.

Additionally, healthcare providers should counsel patients to consult a doctor and discontinue use if their cough persists for more than one week, tends to recur, or is accompanied by fever, rash, or a persistent headache. This guidance is essential to ensure patient safety and appropriate management of symptoms.

Storage and Handling

This product is supplied in various package configurations, with specific NDC numbers available for identification. It should be stored at room temperature, ensuring that it is kept away from excessive heat.

Special handling precautions must be observed: the product must not be exposed to flame, nor should it be placed in any container intended for heating water. Additionally, it is imperative that the product is never placed in a microwave oven. Proper adherence to these storage and handling guidelines is essential to maintain the integrity of the product.

Additional Clinical Information

The product is administered topically, specifically for adults and children over the age of 2 years. Patients are instructed to apply a thick layer to the chest and throat to achieve temporary relief from nasal congestion and coughing associated with colds. If desired, the application can be covered with a dry, warm cloth, ensuring that clothing remains loose to allow vapors to rise to the nose and mouth. This application may be repeated up to three times daily, particularly at bedtime, or as directed by a healthcare professional. For children under the age of 2 years, consultation with a doctor is recommended prior to use.

No additional information is available regarding laboratory tests, abuse potential, patient counseling, or postmarketing experience.

Drug Information (PDF)

This file contains official product information for Assured Vaporizing Chest Rub, including active ingredients, dosage, warnings, and labeling as submitted by the manufacturer for OTC distribution.

View product document (PDF)